ALL
Pharma in China
Pharma Experts
Market News
Products Guide
Brand Story
-
Thrombolytic Science Initiates Phase 2 Clinical Trial of its Novel Treatment Regimen for Ischemic Stroke
September 06, 2018Study Seeks to Confirm Efficacy and Safety of Next-generation Clot-dissolving Therapy Consisting of Low-dose tPA and HisproUK -
Thrombolytic Science to Present at the 15th Anglo Nordic Life Science Investor Conference
June 04, 2018Thrombolytic Science, LLC (TSI), a clinical stage vascular health company developing biotechnology products to treat thrombotic diseases such as heart attacks and stroke, -
Thrombolytic Science to Participate in 2018 BIO International Conference
June 04, 2018Thrombolytic Science, LLC (TSI), a clinical stage vascular health company developing biotechnology products to treat thrombotic diseases such as myocardial infarction (MI, or heart attack) and stroke
Pharma Sources Insight January 2025
